1. GSK aims to make 1B doses of vaccine booster for multiple COVID-19 partners — Protalix and Chiesi get close to potential Fabry disease treatment approval — AstraZeneca locks up COVID-19 vaccine supply with Oxford BioMedica deal — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice


Discussion in 'Vaccines' started by Anonymous, May 2, 2011 at 7:24 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Can anyone shed some light on Crucell? How are they to work for? I know they were just bought out buy J&J....but I'm trying to get a feel for the quality of their products.

    I've got an offer coming in. I'm currenty in "big pharma" and doing well. The attraction with Crucell is going to a smaller company and have a vertical call point (GP's, specialists, pharmacies, travel clinics, key accounts).

    The compensation seems to be the same as what I'm currently getting, so it's a lateral move in that regard. The opportunity for career development seems better as there might be some expansions happening in the future.

    Any thoughts?